Atlas Trials

Hypertension and Arrhythmias in CLL Patients Treated With BTK Inhibitors

Clinical trial NCT06211413 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT06211413
Sponsor
Abramson Cancer Center at Penn Medicine
Status
ENROLLING_BY_INVITATION
Study type
OBSERVATIONAL
Chronic Lymphocytic LeukemiaAtrial FibrillationHypertensionCardiotoxicity
Start date
2024-02-07
Primary completion
2026-08-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.